Author index (vol. 9)

304

Author Index (Vol. 9)

Agren.

H. and

maJor

Terenius.

depression

aminergic Alarcon.

and

R.D..

Tolbert.

Kemp.

metabolism

S.A..

Peet.

caesmm.

Ward,

other

elements

M., see Pare. N.C.,

see Coryell.

Andreasen,

N.C..

see Lewis.

Bjrrre.

M.. see Mnller,

Breier.

A., see Roy. N.

CnaJor

and

Davis.

assessement

symptoms),

C.L.,

see Miller.

A.L..

Endicott,

J.. see Coryell. J.. see Lewis.

levels

of vanadium.

patients).

Faravelli.

C. (Life

(Short

187

Cadoret.

D.. see Hanin,

R.J..

Carney.

Clayton, (The

G.N..

E.. see Merikangah.

K.R..

A.. bee Hanin.

DSM-III of

criteria

the

in

descriptwe

Cook.

factors

E. and in major

C.E.,

(Phenomenology depression).

I., Koslow.

Coryell.

vegetative

Test

Nurnberg.

in depressive,

psychosls).

R. (Outcome major

secondary J..

symptoms

wick,

D.. Frazer.

fluid

levels

M.J.. and

-

depression).

Kocsis.

major

Keller.

family

depression),

M.

and

history

see

Healy.

D..

Carney,

pression

265

in chronic

pain

0165-0327,'85/$03.30 10 1985 Elsevier

Pelton.

P.V..

P.A..

Changes

trazodone

C.L..

Bruns-

E. (Cerebrosptnal imipramine

IO plasma

and

levels

and

165

O’Halloran. and

A. and serotonin

associated

wth

or amltriptyline).

E.. see Cadoret,

J.D..

Bowden.

Robins,

Relationship

adrenoceptora ~

J.H.,

R.J..

Leonard. receptors

response

B.E. i” de-

to treatment

285 155

M., 47

see Kronfol,

Z.. 169

Judd,

F.K.,

basis

Burrows,

of anxiety

G.D.

and

Norman,

An overwew).

T.R.

(The

biological

271

psychotic

S. (Neuro-

and depression),

Science

in

Communi-

G., 63

Rabina,

G.. see Kerkhofs.

Keitner.

R. and

S. (Ke-

69

Hoffman,

N.C.

M.. 181

R.. France,

M. age

progno-

Andreasen,

in DSM-III

Ahlex.

(Short

nortriptyline.

~

Heywood, House.

Haag,

matched

nonsuppression

study)

J. and

of amitrlptyline.

K.. see Ulrich.

non-

149

B. (Short-term

A. and

dexamethasone

A.. Carl,

K..

(Peripheral

therapy

Halaris.

and

wth

W.. 1 S.H.,

Harris.

with

M.I.

A study

A negative

coutome).

H.G.

13

J.. Krishna”,

loss

Harms.

107

with desipramine

M. and Pfohl.

W.. see Zimmerman.

Davidson,

A. and

S.. 219

and

Gitlm.

~

193

M.. see Greil.

E.. 249

Mairhofer.

in the elderly

patients

Haag.

253

of nonpsychotic and

H.E.. weight

treatment

schizo-affective

Endicott.

1

Hanin.

Z., 169

W.. Zimmerman. W.,

5

137

M.C..

desmethylimipramine

Suppression

sis in primary Coryell.

groups),

Troughton,

19

Dexamethasone

in autotypes Coryell.

A.C..

see Lykouras.

W. and Turner.

dosage

depression).

D.. 285

B.L.. see Shukla.

C‘oryell.

(Lithium

catlo”).

Heywood.

C.M.B..

W.. Stoltzenburg.

ported

271

J.. Rothpearl,

and

disorder

I.. 69

V.. see Pare.

Greil.

depressed

Prudic,

depressive

of panic

S.E., 223

Fraxr,

I.. 69

S.. see Kronfol.

E.F..

the onset

103

F., see Moller,

Gwirtsman.

T.W.,

see Whittera.

P.. see Lewis.

Coccaro.

preceding

Frank.

199

and environmental

P.A.. see Healy.

Chapman.

wents

Communication),

J.. 213

115

F.K.,

O’Gorman,

Chriatodoulou,

253

R.. see Davidson.

I., 69

see Judd,

J., see Hanin.

W.. 13 C.E.,

France.

155 Carl,

M.. 47

A. 143

297

253

A”

Bowden.

R.J.,

see Roy,

Endicott.

Glovcr.

1.. 69

E. (Genetic

N., 199

V.. see Kerkhofs.

A.R..

Fog-Moller,

(Refining

see Hanin,

Cadoret.

A

137

G.C.

-

of criterion

G.D..

see Breslau.

S.E.. 223

C.L.,

Burrows.

~

W.. 13

Bowden. Brunswick,

(One-

disorders

in depressive

C.E.,

G.C.,

D.A..

J.R.

A.. 143

depression

validity

Morere.

in affective

C.M.B..

Andreasen.

Breslau.

J.A..

Smythiea,

(Blood

Davis.

De Martelaere. Dora”.

Monti.

N.I.

with mono-

25

Communication),

M. and

and

Al Mousawi.

(Short

CSF

B. and

disturbances

report)

in patients

between

indices).

L.C..

W.G..

preliminary Ali.

Interactions

endorphinergic

Walter-Ryan. carbon

L. (Hallucinations

~

Pub1isher.r

G.I..

see Norman.

W.H..

Kcllcr.

M.. see Coryell,

W.. 13

Kemp,

B., ,ee Alarcon.

R.D..

Kerkhofs.

M.. Hoffman,

213 B.V. (Biomedical

Division)

97

297

G., De Martelaere.

V.. Linkowski.

P.

305 and Mendlewicz, J. (Sleep EEG recordings in depressive disorders). 47 Kirk, L.. see Moller, SE., 223 Knudsen, A.. see Moller. S.E., 223 Kocsis. J.H.. see Hanin. I., 69 Koven. S.. see Rabins, P.V.. 165 Koslow, S.H., see Hanin, I.. 69 Krishnan. R., see Davidson, J., 213 Kronfol, Z.. Nasrallah, H.A., Chapman, S. and House, J.D. (Depression. cortisol metabolism and lymphocytopenia), 169 Kuhs, H. (Dexamethasone Suppression Test and sleep deprivation in endogenous depression), 121 Kupfer, D.J., see Merikangas. K.R., 5 Lee. N.F., Rush, A.J. and Mitchell, J.E. (Dulimia and depression), 231 Leonard, B.E., see Healy. D.. 285 Lewis, C.E.. Rice, J.. Andreasen, N., Clayton, P. and Endicott. J. (Alcoholism in antisocial and nonantisocial men with unipolar major depression), 253 Lewis, D.A. and McChesney, C. (Tritiated imipramine binding to platelets in manic subjects). 207 Linkowski. P., see Kerkhofs. M., 47 Loyd. D.W. and Twang. M.T. (Duration criteria and long-term outcome in affective disorder and schizophrenia), 35 Lykouras, E.. Christodoulou. G.N. and Malliaras, D. (Type and content of delusions in unipolar psychotic depression), 249 McChesney, C.. see Lewis, D.A.. 207 Mairhofer, M.I., see Creil, W., 1 Malliaras, D.. see Lykouras, E.. 249 Mazure, C., see Nelson, J.C.. 41 Mendlewicz. J.. see Kerkhofs, M., 47 Merikangas. K.R., Prusoff, B.A.. Kupfer. D.J. and Frank. E. (Marital adjustment in major depression), 5 Miller. A.L. Bowden. C.L. and Plewes, J. (Lithium and impairment of renal concentrating ability), 115 Miller. I.W.. see Norman. W.H.. 97 Miller. M.G.. see Shukla, S., 219 Mitchell, J.E., see Lee. N.F., 231 Mailer, SE., Odum. K., Kirk, L., Bjerre, M., Fog-Moller, F. and Knudsen. A. (Plasma tyrosine/neutral amino acid ratio correlated with clinical response to nortriptyline in endogeneously depressed patients). 223 Monti. J.A., see Alarcon. R.D.. 297 Morere. D.S.. see Alarcon. R.D., 297 Mott, J., see Waziri. R., 175 Mullaney. J.A. (The validity of two Newcastle Diagnostic Scales in the affective disorders - Bimodality and other correlates), 239 Nasrallah. H.A., see Kronfol, Z., 169 Nelson, J.C. and Mazure, C. (Ruminative thinking - A distinctive sign of melancholia). 41 Norman, T.R., see Judd, F.K.. 271 Norman. W.H., Keitner. G.I. and Miller, I.W. (MMPI, personality dysfunction and the Dexamethasone Suppression Test in major depression) (Short Communication), 97

Nurnberg. H.G.. see Coccaro, E.F., 107 0dum. K., see Moller, SE.. 223 O’Gorman. O’Halloran,

T.W., see Cadoret. R.J.. 155 A., see Healy, D.. 285

Pare, C.M.B., Al Mousawi, M., Sandler, M. and Clover. V. (Attempts to attenuate the “cheese effect” - Combined drug therapy in depressive illness), 137 Paykel. E.S. (The clinical interview for depression ~ Development, reliability and validity). 85 Peet. M., see Ali, S.A., 167 Pelton, S., see Davidson, J.. 213 Pfohl, B., see Coryell, W., 265 Pfohl. B., see Zimmerman, M.. 181 Pfohl. B., see Sherman. B.M., 55 Pickar. D., see Roy, A.. 143 Plewes, J.. see Miller, A.L., 115 Prudic. J., see Coccaro, E.F., 107 Prusoff, B.A., see Merikangas. K.R., 5 Rabins, P.V., Harvis, K. and Koven, S. (High fatality rates of late-life depression associated with cardiovascular disease), 165 Rise, J., see Lewis, C.E., 253 Robertson. M.M. and Trimble, M.R. (The treatment of depression in patients with epilepsy - A double-blind trial). 127 Robins. E., see Hanin. I., 69 Robinson, D.G. and Spiker. D.G. (Delusional depression ~ A one year follow-up), 79 Rothpearl, A., see Coccaro. E.F., 107 Roy, A.. Breier, A., Doran. A.R. and Pickar. D. (Life events in depression - Relationship to subtypes). 143 Rush. A.J., see Lee. N.F.. 231 Sandier, M.. see Pare, C.M.B., 137 Sherman, B.M. and Pfohl, B. (Rhythm-related changes in pituitary-adrenal function in depression), 55 Shukla, S., Cook, B.L. and Miller, M.G. (Lithium-carbamazepine versus lithium-neuroleptic prophylaxis is bipolar illness), 219 Smythies, J.R.. see Alarcon, R.D., 297 Spiker, D.G.. see Robinson, D.G.. 79 Stoltzenburg. M.C., see Greil, W., 1 Terenius, L., see Agren, H., 25 Tolbert, L.C., see Alarcon. R.D., 297 Trimble, M.R., see Robertson. M.M.. 127 Troughton, E., see Cadoret, R.J., 155 Tsuang, M.T., see Loyd. D.W., 35 Turner, R.. see Coryell, W., 149 Ulrich, G. and Harms, K. (A video analysis of the non-verbal behaviour of depressed patients before and after treatment), 63 Walter-Ryan, W.G., see Alarcon, Ward. N.I., see Ali, S.A.. 167

R.D., 297

306

Wuirl, from Whitten. &ted Widmer,

R.. Molt.

.I. and Wilcox.

nonapychotic A.C.. with R.B..

Cadoret. suicide

J. (Differentiation

depression

by a biological

R.J. and attempts

see Whltters.

Widmer.

in alcohol

A.C..

19

of psychotic marker).

R.B. (Factors abuse).

175 XSSO-

Wilcox.

J., see Waziri.

Zimmerman.

M.m

and dimensional

R.. 175

Coryrll. models

W. and

Pfohl.

of endogenous

1Y Zimmerman.

M.. see Coryell.

W.. 265

B. (The

categorical

depression).

181